Format

Send to

Choose Destination
Cancer Commun (Lond). 2019 Apr 15;39(1):18. doi: 10.1186/s40880-019-0364-x.

Target delineation and dose prescription of adaptive replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma.

Author information

1
Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, 651 Dong Feng Road East, Guangzhou, 510060, Guangdong, P. R. China.
2
Department of Oncology, Shunde Hospital of Southern Medical University, Foshan, 528399, Guangdong, P. R. China.
3
Department of Radiation Oncology, Hainan General Hospital, Haikou, 570100, Hainan, P. R. China.
4
Department of Radiation Oncology, National Cancer Center/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, Guangdong, P. R. China.
5
Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, 651 Dong Feng Road East, Guangzhou, 510060, Guangdong, P. R. China. suyong@sysucc.org.cn.
6
Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, 651 Dong Feng Road East, Guangzhou, 510060, Guangdong, P. R. China. xiayf@sysucc.org.cn.
PMID:
30987678
DOI:
10.1186/s40880-019-0364-x
Free full text

Supplemental Content

Full text links

Icon for BioMed Central
Loading ...
Support Center